Literature DB >> 33727928

Bloodstream Infection Etiology among Children and Adults.

Svetlana I Kolesnichenko1, Alyona V Lavrinenko1, Lyudmila L Akhmaltdinova1.   

Abstract

Every year in the world, sepsis occurs in 31.5 million people, and the number of deaths reaches 5.3 million per year. There are not enough studies that describe etiological structure of sepsis pathogens in different groups of population of the Republic of Kazakhstan. In this study, we have investigated difference of local sepsis etiology and antibiotic susceptibility among children and adults. A total 200 blood samples were examined using the standard and express method of identification of bloodstream pathogens. The determination of antimicrobial sensitivity was carried out by the disc-diffusion method according to CLSI guidelines. Overall, 23/90 (25.5%) positive blood cultures were isolated from adult patients and 43/110 (39%) from pediatric patients. It was found that children are statistically more often affected with bacterial bloodstream infection than adults (p < 0.05). The Gram-positive bacteria are the leading cause of sepsis in both groups: S. epidermidis (35.5%) in pediatric patients and S. aureus (21.7%) in adults. However, statistical significance was detected in pediatric patients (p < 0.05). The number of resistant strains of S. epidermidis (MRSE) in the group of children was 66.7%, while in adults, all S. epidermidis was resistant to azithromycin and cefoxitin (MRSE). S. aureus strains from adult patients and children had a similar picture of antibiotic patterns. The proportion of MRSA in pediatric patients was 16, 6%, and in adult patients, 20%. Enterobacterales (39%) were the second cause of sepsis in adult patients. 62.5% of Enterobacterales strains isolated from adults were phenotypically identified as ESBL, while in pediatric patients, 25% of ESBL producers were isolated. We have noted the resistance to antibiotics that are prescribed according to protocols of treatment of the Republic of Kazakhstan in the strains isolated from the patient's blood.
Copyright © 2021 Svetlana I. Kolesnichenko et al.

Entities:  

Year:  2021        PMID: 33727928      PMCID: PMC7939735          DOI: 10.1155/2021/6657134

Source DB:  PubMed          Journal:  Int J Microbiol


  20 in total

1.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  Rapid and cost-effective identification and antimicrobial susceptibility testing in patients with Gram-negative bacteremia directly from blood-culture fluid.

Authors:  Christina Sakarikou; Anna Altieri; Maria Cristina Bossa; Silvia Minelli; Camilla Dolfa; Micol Piperno; Cartesio Favalli
Journal:  J Microbiol Methods       Date:  2018-02-03       Impact factor: 2.363

3.  Epidemiology and microbiology of sepsis in mainland China in the first decade of the 21st century.

Authors:  Xin-Chuan Chen; Yun-Fan Yang; Rui Wang; Hong-Feng Gou; Xin-Zu Chen
Journal:  Int J Infect Dis       Date:  2014-11-29       Impact factor: 3.623

4.  Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study.

Authors:  Scott L Weiss; Julie C Fitzgerald; John Pappachan; Derek Wheeler; Juan C Jaramillo-Bustamante; Asma Salloo; Sunit C Singhi; Simon Erickson; Jason A Roy; Jenny L Bush; Vinay M Nadkarni; Neal J Thomas
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

5.  Neonatal sepsis 2004-2013: the rise and fall of coagulase-negative staphylococci.

Authors:  Matthew J Bizzarro; Veronika Shabanova; Robert S Baltimore; Louise-Marie Dembry; Richard A Ehrenkranz; Patrick G Gallagher
Journal:  J Pediatr       Date:  2015-05       Impact factor: 4.406

6.  Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: Prevalence, predictive factors, therapeutic outcome.

Authors:  Lidia Santarpia; Antonio Buonomo; Maria Carmen Pagano; Lucia Alfonsi; Maria Foggia; Michele Mottola; Geremia Zito Marinosci; Franco Contaldo; Fabrizio Pasanisi
Journal:  Clin Nutr       Date:  2016-03-30       Impact factor: 7.324

7.  Intravenous device associated blood stream staphylococcal infection in paediatric patients.

Authors:  Amita Jain; Astha Agarwal; Raj Kumar Verma; Shally Awasthi; K P Singh
Journal:  Indian J Med Res       Date:  2011-08       Impact factor: 2.375

8.  Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Enterobacteriaceae Isolated from Egyptian Patients with Suspected Blood Stream Infection.

Authors:  H M Abdallah; B B Wintermans; E A Reuland; A Koek; N al Naiemi; A M Ammar; A A Mohamed; C M J E Vandenbroucke-Grauls
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

9.  Polymicrobial bloodstream infection in neonates: microbiology, clinical characteristics, and risk factors.

Authors:  Ming-Horng Tsai; Shih-Ming Chu; Jen-Fu Hsu; Reyin Lien; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Chiang-Wen Lee; Yhu-Chering Huang
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

10.  Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China.

Authors:  Su Wang; Sheng-Yuan Zhao; Shu-Zhen Xiao; Fei-Fei Gu; Qing-Zhong Liu; Jin Tang; Xiao-Kui Guo; Yu-Xing Ni; Li-Zhong Han
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more
  1 in total

1.  Microbial Landscape and Antibiotic Susceptibility Dynamics of Skin and Soft Tissue Infections in Kazakhstan 2018-2020.

Authors:  Sholpan S Kaliyeva; Alyona V Lavrinenko; Yerbol Tishkambayev; Gulzira Zhussupova; Aissulu Issabekova; Dinara Begesheva; Natalya Simokhina
Journal:  Antibiotics (Basel)       Date:  2022-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.